PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22420940 ↗2012Reported benefit

Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions.

MouseChemical/toxinCD1Malen = 6 mice per groupOral gavage in a volume of 2.5 mL/kg; intravenous for pharmacokinetics0.3 and 1 mg/kg for the gastric lesion study; 0.1-3 mg/kg (…Administered orally at the same time as indomethacin; in pain models given once…

Model: Indomethacin-induced gastric lesions, with parallel carrageenan inflammation, chronic sciatic nerve ligation and complete Freund's adjuvant arthritis models

Oral URB937 dose-dependently reversed hyperalgesia and allodynia, acted synergistically with indomethacin, and reduced the number and severity of indomethacin-induced gastric lesions.

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.